Analyst consensus rating
Imunon Analyst Rating: Strong Buy
IMNN is rated Strong Buy by 5 analysts with a $17.00 target. As of 2026-08-27.
Direct answer
Imunon's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $17.00.
Forecast evidence checked August 27, 2026.
Get free Imunon email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.63
- Average price target
- $17.00
- High price target
- $25.00
- Low price target
- $10.00
- Low target gap
- +513.5%
- Target upside
- +942.9%
- High target gap
- +1,433.7%
- Target range width
- 920.2%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Imunon?
Imunon has a verified Strong Buy consensus. The same dataset has an average price target of $17.00.
How far are Imunon's low and high targets from the recorded price?
The low target implies +513.5%, while the high target implies +1,433.7%.
How many analysts are included in Imunon's consensus?
The verified consensus includes 5 analysts.
How is Imunon's target upside or downside calculated?
The average target of $17.00 is divided by the recorded price of $1.63, then one is subtracted to produce +942.9%. This does not guarantee a future return.
When was Imunon's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.